Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Jeff Bezos has come a long way in the past 30 years — as has the company he founded in 1994, Amazon.com Inc. (ticker: AMZN). Amazon ranks as the No. 2 company in the world by ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Sana Biotechnology and Vertex Pharmaceuticals ... Washington’s most successful biotech companies, Seagen and Chinook Therapeutics, and is now an investor with Samsara BioCapital.

Life Science Washington, the state’s life sciences industry association, today announced the expansion of its board of directors with the addition of nine new members, representing distinguished ...

Biotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In January, several biotech names saw explosive gains as investors bet on ...

Also on Thursday, Maze Therapeutics priced an upsized IPO at $16 a share, in the middle of a marketed range, according to a statement. The maker of biopharmaceutical medicine for kidney ...

Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support ...